Health Care/Hospital

Bioved Pharmaceuticals granted a US Patent for its oral, natural plant-based product, Artovid-20® for the treatment of Covid-19

SAN JOSE, Calif., April 26, 2023 /PRNewswire/ -- Bioved Pharmaceuticals, Inc. is proud to announce that it has received a US Patent for its natural Ayurved based product, Artovid-20® Tablets for Covid-19. The Patent titled "Methods and Compounds for Treating Effects of Covid-19 Disease," grants 2...

2023-04-26 03:00 1660

IF YOU, A CHILD IN YOUR CARE, OR ANOTHER LOVED ONE WERE HARMED BY ENDO OR A RELATED COMPANY, INCLUDING PAR OR AMS, OR THEIR PRODUCTS INCLUDING OPIOIDS, RANITIDINE, OR TRANSVAGINAL MESH, YOUR RIGHTS MAY BE AFFECTED BY DEADLINES IN THE ENDO BANKRUPTCY.

The deadline to file a claim in the bankruptcy is July 7, 2023, at 5:00 p.m. (prevailing Eastern Time). The deadline to object to Endo's sale is July 7, 2023, at 4:00 p.m. (prevailing Eastern Time). NEW YORK, April 25, 2023 /PRNewswire/ -- The following is being issued by Kroll Restructuring Adm...

2023-04-25 22:27 1821

Call for submissions for the 6th edition of the SophI.A Summit, the annual event for academic and business research on artificial intelligence

* National and international  researchers and R&D leaders are invited to submit  their work for presentation as  a conference,  a poster or a demonstration. * The most promising communications  will be awarded  Special Prizes which include  grants of several thousand euros. SOPHIA ANTIPOLIS, ...

2023-04-25 22:05 1808

ZEISS Announces U.S. FDA Approval of the CT LUCIA 621P Monofocal IOL, Offering the Unique ZEISS Optic to the U.S. Market

The monofocal IOL enables surgeons to treat a wide range of cataract patients while supporting optimized visual outcomes. JENA, Germany and DUBLIN, Calif., April 25, 2023 /PRNewswire/ -- Today, ZEISS Medical Technology announced the U.S. Food and Drug Administration (FDA) has approved theCT LUCI...

2023-04-25 21:00 1733

Emmes Applauded by Frost & Sullivan for Streamlining Clinical Trials and for Its Competitive Strategies

Emmes collaborates with pharmaceutical companies as strategic partners, providing one-stop clinical trial services, reducing costs, and accelerating development. SAN ANTONIO, April 25, 2023 /PRNewswire/ -- Frost & Sullivan researched the contract research organizations industry and, based on its...

2023-04-25 20:30 1539

Wellcome Leap & Temasek Trust Launch US$60M Dynamic Resilience Programme to Extend Health Spans

* Average human life expectancy has doubled from 35 to 70 years over the past century[1], but health spans (number of years spent in good health) have not correspondingly improved[2]   * Multimorbidity (multiple coexisting health conditions) poses an urgent challenge for global health service...

2023-04-25 20:03 1666

Nippon Express (UK) Receives IATA CEIV Pharma Certification for Its Facility in Heathrow Airport Suburb

TOKYO, April 25, 2023 /PRNewswire/ -- Nippon Express (UK) Ltd. (hereinafter "NXUK"), a group company of NIPPON EXPRESS HOLDINGS, INC., has been awarded IATA CEIV Pharma certification*, a quality certificate for pharmaceutical transport established by the International Air Transport Association (I...

2023-04-25 15:00 1854

CGTN: Why is China committed to aiding countries in need?

BEIJING, April 25, 2023 /PRNewswire/ -- Sixty years have passed since China dispatched its first batch of medical teams toAlgeria in 1963. Since then, more than 30,000 medical workers have been sent to 76 countries and regions, providing medical services to 290 million people, said a Chinese Fore...

2023-04-25 14:36 2329

Utilizing Term Life to Hedge an Average of HK$1.9 Million Protection Gap Amongst Hongkongers

HONG KONG, April 25, 2023 /PRNewswire/ -- It is often wise to plan for the worst and prepare for the best in all matters. When people plan for their future, they often consider the possibility of an untimely death as the family breadwinner. They worry that if this unfortunate event happens, their...

2023-04-25 14:15 2090

Biotech firm Gene Solutions: A promising picture for multi-cancer early detection in Southeast Asia

HO CHI MINH CITY, Vietnam, April 25, 2023 /PRNewswire/ -- In January 2023, Vietnam's Medical Genetics Institute & Gene Solutions  published their research paper on Cancer Investigation:Clinical validation of a ctDNA-based assay for multi-cancer detection: an interim r...

2023-04-25 12:00 1876

2,800 Singapore Students to Benefit from new STEM Partnership

Year Long Programme with Science Centre Singapore to kick off on World DNA Day as part of Illumina's Future is Bright Initiative. SINGAPORE, April 25, 2023 /PRNewswire/ -- Illumina Singapore, subsidiary of Illumina Inc (NASDAQ: ILMN) today announced an inaugural partnership with the Science Centr...

2023-04-25 10:00 659

Mediso launches next generation MRI spectrometer spinScan®

BUDAPEST, Hungary, April 25, 2023 /PRNewswire/ -- Mediso released their next generation MRI spectrometer spinScan® the successor to the previously used console in the nanoScan® MRI product line. The new spectrometer was optimized for MRI applications delivering an ultra-low-...

2023-04-25 09:00 1734

GATE Energy PTE LTD Achieves bizSAFE STAR Certificate in Singapore

SINGAPORE, April 25, 2023 /PRNewswire/ -- GATE Energy PTE LTD in Singapore has been officially awarded the bizSAFE STAR Certificate. bizSAFE is a nationally recognized program designed to help companies build workspace safety and health capabilities. bizSAFE is a 5-step program with the bizSAFE S...

2023-04-25 00:39 2326

Medical Aesthetics and Technology Leader Cynosure Appoints Nadav Tomer as its Chief Executive Officer

Seasoned med-tech executive to advance Cynosure's growth and innovation strategy and strengthen the company's position as the medical aesthetics technology leader WESTFORD, Mass., April 24, 2023 /PRNewswire/ -- Cynosure, LLC ("Cynosure" or the "Company"), a leader in medical aesthetics systems a...

2023-04-24 21:01 2032

International Health Industry Forum of Boao Forum for Asia Held in Beijing

BEIJING, April 24, 2023 /PRNewswire/ -- The International Health Industry Forum of Boao Forum forAsia (BFA) was held from April 20th-21st in Beijing. A special forum under the framework of the Global Health Forum of Boao Forum forAsia (GHF), the event was jointly hosted by the Boao Forum for Asia...

2023-04-24 20:14 1883

BMC H-80 series: empowering breathing solutions for breathing and oxygen therapy

BEIJING, April 24, 2023 /PRNewswire/ -- Recently, the H-80 series Respiratory High-Flow Therapy Device has added more comprehensive monitoring indicators for even greater convenience and efficiency to help people in respiratory failure.   April is a crucial month to prioritize the respiratory hea...

2023-04-24 20:00 1594

Daewoong Pharmaceutical Announce Publication of Phase 3 Study of 'Envlo', a New Treatment for Diabetes, in the International SCIE Journal

SEOUL, South Korea, April 24, 2023 /PRNewswire/ -- The research results of Daewoong Pharmaceutical's SGLT-2 inhibitor new drug, 'Envlo', have been internationally acknowledged. On April 4, Daewoong Pharmaceutical (CEO Seng-ho Jeon and Chang-jae Lee) announced that the efficacy and safety evalu...

2023-04-24 14:53 2032

Belief BioMed Announces a Key Milestone of Dosing Completion for All Subjects in its Registrational Clinical Trial of BBM-H901

SHANGHAI, April 24, 2023 /PRNewswire/ -- Belief BioMed Group (BBM), an industry-leading biotech company focusing on innovative gene therapies, announced today the completion of patient dosing in its Phase III Registrational Clinical Trial (CTR20212816) of BBM-H901, a gene therapy for Hemophilia ...

2023-04-24 10:23 2051

SCG Cell Therapy to Present Late-Breaking Data at the International Society for Cell & Gene Therapy (ISCT) Highlighting Promising Antitumor and Antiviral Activities of SCG101 in Treating HBV-Related Hepatocellular Carcinoma

SINGAPORE, April 24, 2023 /PRNewswire/ -- Singapore based SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, today announced that late-breaking data from the company's TCR-T therapy pipeline...

2023-04-24 10:00 2130

Everest Medicines Launches Nefecon in China's Hainan Boao Pilot Zone as a First-in-Disease Therapy for IgA Nephropathy

SHANGHAI, April 24, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest," or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, announced today that Nefecon, the first-in-disease treatment fo...

2023-04-24 07:44 2312
1 ... 100101102103104105106 ... 554